Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H15N3O |
Molecular Weight | 217.267 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC1=C(C)N(C)N(C1=O)C2=CC=CC=C2
InChI
InChIKey=JILCEWWZTBBOFS-UHFFFAOYSA-N
InChI=1S/C12H15N3O/c1-9-11(13-2)12(16)15(14(9)3)10-7-5-4-6-8-10/h4-8,13H,1-3H3
Molecular Formula | C12H15N3O |
Molecular Weight | 217.267 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. | 2001 Nov |
|
Limited-sampling strategy models for estimating the pharmacokinetic parameters of 4-methylaminoantipyrine, an active metabolite of dipyrone. | 2001 Nov |
|
Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators. | 2001 Sep |
|
Allergic cholestatic hepatitis and exanthema induced by metamizole: verification by lymphocyte transformation test. | 2002 Dec |
|
Bioavailability of two metamizole (dipyrone) solutions as single doses of 2 g versus metamizole capsules. | 2002 Jul |
|
Benzydamine: an alternative nonsteroidal anti-inflammatory drug in patients with nimesulide-induced urticaria. | 2002 May |
|
Effect of metamizol on promyelocytic and terminally differentiated granulocytic cells. Comparative analysis with acetylsalicylic acid and diclofenac. | 2003 Jan 15 |
|
Simultaneous determination of residues of dipyrone and its major metabolites in milk, bovine muscle, and porcine muscle by liquid chromatography/mass spectrometry. | 2005 Mar-Apr |
|
Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic. | 2007 Aug |
|
Solid-phase extraction followed by liquid chromatography-time-of-flight-mass spectrometry to evaluate pharmaceuticals in effluents. A pilot monitoring study. | 2007 Jul |
|
Inhibition of cyclooxygenases by dipyrone. | 2007 Jun |
|
[Analysis of three metabolite residues of dipyrone in bovine muscle and pork muscle using high performance liquid chromatography]. | 2007 Nov |
|
[Favorable outcome of acute porphyric neuropathy after treatment with heme arginate]. | 2007 Nov |
|
Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury. | 2008 |
|
Photodegradation study of three dipyrone metabolites in various water systems: identification and toxicity of their photodegradation products. | 2008 May |
|
Treatment of postherpetic neuralgia: focus on pregabalin. | 2009 |
|
Quantification of 4-methylaminoantipyrine, the active metabolite of dipyrone, in human plasma. | 2009 May |
|
Investigation of the microbial degradation of phenazone-type drugs and their metabolites by natural biofilms derived from river water using liquid chromatography/tandem mass spectrometry (LC-MS/MS). | 2010 Aug |
|
Population pharmacokinetic analysis of the active product of dipyrone. | 2010 Dec |
|
Scavenging activity of aminoantipyrines against hydroxyl radical. | 2010 Jun |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:46:27 GMT 2023
by
admin
on
Fri Dec 15 17:46:27 GMT 2023
|
Record UNII |
NER31DE951
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
519-98-2
Created by
admin on Fri Dec 15 17:46:27 GMT 2023 , Edited by admin on Fri Dec 15 17:46:27 GMT 2023
|
PRIMARY | |||
|
NER31DE951
Created by
admin on Fri Dec 15 17:46:27 GMT 2023 , Edited by admin on Fri Dec 15 17:46:27 GMT 2023
|
PRIMARY | |||
|
SUB14664MIG
Created by
admin on Fri Dec 15 17:46:27 GMT 2023 , Edited by admin on Fri Dec 15 17:46:27 GMT 2023
|
PRIMARY | |||
|
73261
Created by
admin on Fri Dec 15 17:46:27 GMT 2023 , Edited by admin on Fri Dec 15 17:46:27 GMT 2023
|
PRIMARY | |||
|
DTXSID80199865
Created by
admin on Fri Dec 15 17:46:27 GMT 2023 , Edited by admin on Fri Dec 15 17:46:27 GMT 2023
|
PRIMARY | |||
|
C008667
Created by
admin on Fri Dec 15 17:46:27 GMT 2023 , Edited by admin on Fri Dec 15 17:46:27 GMT 2023
|
PRIMARY | |||
|
10618
Created by
admin on Fri Dec 15 17:46:27 GMT 2023 , Edited by admin on Fri Dec 15 17:46:27 GMT 2023
|
PRIMARY | |||
|
208-281-3
Created by
admin on Fri Dec 15 17:46:27 GMT 2023 , Edited by admin on Fri Dec 15 17:46:27 GMT 2023
|
PRIMARY | |||
|
100000080001
Created by
admin on Fri Dec 15 17:46:27 GMT 2023 , Edited by admin on Fri Dec 15 17:46:27 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
Metamizole is rapidly hydrolyzed to 4-MMA in gastric juice and this is the predominat species absorbed.
MAJOR
PLASMA; URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|